Monoclonal Antibodies (MAbS) Global Market Report 2023

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,000	250 Pages	The Business Research Company	February, 2023	BRC17692785

Best Price Guarantee
Price	from $5,000
Length	250 Pages
Publisher	The Business Research Company
Published Date	February, 2023
SKU	BRC17692785

Monoclonal Antibodies (MAbS) Global Market Report 2023

Monoclonal Antibodies (MAbS) Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on monoclonal antibodies (mabs) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for monoclonal antibodies (mabs) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The monoclonal antibodies (mabs) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

Markets Covered:1) By Source: Murine; Chimeric; Humanized; Human

2) By Application: Anti-Cancer; Immunological; Anti-Infective Monoclonal Antibodies (MAbs); Neuropharmacological; Cardiovascular And Cerebrovascular; Other Applications

3) By End Users: Hospitals; Private Clinics; Research Institute

Companies Mentioned: Johnson & Johnson; Merck; AbbVie; Amgen; Glaxosmithkline plc

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

1. Executive Summary
2. Monoclonal Antibodies (MAbS) Market Characteristics
3. Monoclonal Antibodies (MAbS) Market Trends And Strategies
4. Monoclonal Antibodies (MAbS) Market – Macro Economic Scenario: 4.1 COVID-19 Impact On Monoclonal Antibodies (MAbS) Market; 4.2 Ukraine-Russia War Impact On Monoclonal Antibodies (MAbS) Market; 4.3 Impact Of High Inflation On Monoclonal Antibodies (MAbS) Market
5. Monoclonal Antibodies (MAbS) Market Size And Growth: 5.1. Global Monoclonal Antibodies (MAbS) Historic Market, 2017-2022, $ Billion; 5.1.1. Drivers Of The Market; 5.1.2. Restraints On The Market; 5.2. Global Monoclonal Antibodies (MAbS) Forecast Market, 2022-2027F, 2032F, $ Billion; 5.2.1. Drivers Of The Market; 5.2.2. Restraints On the Market
6. Monoclonal Antibodies (MAbS) Market Segmentation: 6.1. Global Monoclonal Antibodies (MAbS) Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; Murine; Chimeric; Humanized; Human; 6.2. Global Monoclonal Antibodies (MAbS) Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; Anti-Cancer; Immunological; Anti-Infective Monoclonal Antibodies (Mabs); Neuropharmacological; Cardiovascular And Cerebrovascular; Others; 6.3. Global Monoclonal Antibodies (MAbS) Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; Hospitals; Private Clinics; Research Institute
7. Monoclonal Antibodies (MAbS) Market Regional And Country Analysis: 7.1. Global Monoclonal Antibodies (MAbS) Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 7.2. Global Monoclonal Antibodies (MAbS) Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8. Asia-Pacific Monoclonal Antibodies (MAbS) Market: 8.1. Asia-Pacific Monoclonal Antibodies (MAbS) Market Overview; Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies; 8.2. Asia-Pacific Monoclonal Antibodies (MAbS) Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 8.3. Asia-Pacific Monoclonal Antibodies (MAbS) Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 8.4. Asia-Pacific Monoclonal Antibodies (MAbS) Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
9. China Monoclonal Antibodies (MAbS) Market: 9.1. China Monoclonal Antibodies (MAbS) Market Overview; 9.2. China Monoclonal Antibodies (MAbS) Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion; 9.3. China Monoclonal Antibodies (MAbS) Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion; 9.4. China Monoclonal Antibodies (MAbS) Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
10. India Monoclonal Antibodies (MAbS) Market: 10.1. India Monoclonal Antibodies (MAbS) Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 10.2. India Monoclonal Antibodies (MAbS) Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 10.3. India Monoclonal Antibodies (MAbS) Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11. Japan Monoclonal Antibodies (MAbS) Market: 11.1. Japan Monoclonal Antibodies (MAbS) Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 11.2. Japan Monoclonal Antibodies (MAbS) Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 11.3. Japan Monoclonal Antibodies (MAbS) Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12. Australia Monoclonal Antibodies (MAbS) Market: 12.1. Australia Monoclonal Antibodies (MAbS) Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 12.2. Australia Monoclonal Antibodies (MAbS) Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 12.3. Australia Monoclonal Antibodies (MAbS) Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13. Indonesia Monoclonal Antibodies (MAbS) Market: 13.1. Indonesia Monoclonal Antibodies (MAbS) Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 13.2. Indonesia Monoclonal Antibodies (MAbS) Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 13.3. Indonesia Monoclonal Antibodies (MAbS) Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14. South Korea Monoclonal Antibodies (MAbS) Market: 14.1. South Korea Monoclonal Antibodies (MAbS) Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 14.2. South Korea Monoclonal Antibodies (MAbS) Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 14.3. South Korea Monoclonal Antibodies (MAbS) Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15. Western Europe Monoclonal Antibodies (MAbS) Market: 15.1. Western Europe Monoclonal Antibodies (MAbS) Market Overview; 15.2. Western Europe Monoclonal Antibodies (MAbS) Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 15.3. Western Europe Monoclonal Antibodies (MAbS) Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 15.4. Western Europe Monoclonal Antibodies (MAbS) Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16. UK Monoclonal Antibodies (MAbS) Market: 16.1. UK Monoclonal Antibodies (MAbS) Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 16.2. UK Monoclonal Antibodies (MAbS) Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 16.3. UK Monoclonal Antibodies (MAbS) Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17. Germany Monoclonal Antibodies (MAbS) Market: 17.1. Germany Monoclonal Antibodies (MAbS) Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 17.2. Germany Monoclonal Antibodies (MAbS) Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 17.3. Germany Monoclonal Antibodies (MAbS) Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18. France Monoclonal Antibodies (MAbS) Market: 18.1. France Monoclonal Antibodies (MAbS) Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 18.2. France Monoclonal Antibodies (MAbS) Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 18.3. France Monoclonal Antibodies (MAbS) Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19. Eastern Europe Monoclonal Antibodies (MAbS) Market: 19.1. Eastern Europe Monoclonal Antibodies (MAbS) Market Overview; 19.2. Eastern Europe Monoclonal Antibodies (MAbS) Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 19.3. Eastern Europe Monoclonal Antibodies (MAbS) Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 19.4. Eastern Europe Monoclonal Antibodies (MAbS) Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20. Russia Monoclonal Antibodies (MAbS) Market: 20.1. Russia Monoclonal Antibodies (MAbS) Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 20.2. Russia Monoclonal Antibodies (MAbS) Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 20.3. Russia Monoclonal Antibodies (MAbS) Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21. North America Monoclonal Antibodies (MAbS) Market: 21.1. North America Monoclonal Antibodies (MAbS) Market Overview; 21.2. North America Monoclonal Antibodies (MAbS) Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 21.3. North America Monoclonal Antibodies (MAbS) Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 21.4. North America Monoclonal Antibodies (MAbS) Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22. USA Monoclonal Antibodies (MAbS) Market: 22.1. USA Monoclonal Antibodies (MAbS) Market Overview; 22.2. USA Monoclonal Antibodies (MAbS) Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 22.3. USA Monoclonal Antibodies (MAbS) Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 22.4. USA Monoclonal Antibodies (MAbS) Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23. South America Monoclonal Antibodies (MAbS) Market: 23.1. South America Monoclonal Antibodies (MAbS) Market Overview; 23.2. South America Monoclonal Antibodies (MAbS) Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 23.3. South America Monoclonal Antibodies (MAbS) Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 23.4. South America Monoclonal Antibodies (MAbS) Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24. Brazil Monoclonal Antibodies (MAbS) Market: 24.1. Brazil Monoclonal Antibodies (MAbS) Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 24.2. Brazil Monoclonal Antibodies (MAbS) Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 24.3. Brazil Monoclonal Antibodies (MAbS) Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25. Middle East Monoclonal Antibodies (MAbS) Market: 25.1. Middle East Monoclonal Antibodies (MAbS) Market Overview; 25.2. Middle East Monoclonal Antibodies (MAbS) Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 25.3. Middle East Monoclonal Antibodies (MAbS) Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 25.4. Middle East Monoclonal Antibodies (MAbS) Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26. Africa Monoclonal Antibodies (MAbS) Market: 26.1. Africa Monoclonal Antibodies (MAbS) Market Overview; 26.2. Africa Monoclonal Antibodies (MAbS) Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 26.3. Africa Monoclonal Antibodies (MAbS) Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion; 26.4. Africa Monoclonal Antibodies (MAbS) Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27. Monoclonal Antibodies (MAbS) Market Competitive Landscape And Company Profiles: 27.1. Monoclonal Antibodies (MAbS) Market Competitive Landscape; 27.2. Monoclonal Antibodies (MAbS) Market Company Profiles; 27.2.1. Johnson & Johnson; 27.2.1.1. Overview; 27.2.1.2. Products and Services; 27.2.1.3. Strategy; 27.2.1.4. Financial Performance; 27.2.2. Merck; 27.2.2.1. Overview; 27.2.2.2. Products and Services; 27.2.2.3. Strategy; 27.2.2.4. Financial Performance; 27.2.3. AbbVie; 27.2.3.1. Overview; 27.2.3.2. Products and Services; 27.2.3.3. Strategy; 27.2.3.4. Financial Performance; 27.2.4. Amgen; 27.2.4.1. Overview; 27.2.4.2. Products and Services; 27.2.4.3. Strategy; 27.2.4.4. Financial Performance; 27.2.5. Glaxosmithkline plc; 27.2.5.1. Overview; 27.2.5.2. Products and Services; 27.2.5.3. Strategy; 27.2.5.4. Financial Performance
28. Monoclonal Antibodies (MAbS) Pipeline Analysis
29. Key Mergers And Acquisitions In The Monoclonal Antibodies (MAbS) Market
30. Monoclonal Antibodies (MAbS) Market Future Outlook and Potential Analysis
31. Appendix: 31.1. Abbreviations; 31.2. Currencies; 31.3. Historic And Forecast Inflation Rates; 31.4. Research Inquiries; 31.5. The Business Research Company; 31.6. Copyright And Disclaimer